Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Naoe, T' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 100 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Kiyoi, H; Naoe, T
      Immunoglobulin variable region structure and B-cell malignancies

      INTERNATIONAL JOURNAL OF HEMATOLOGY
    2. Hanamura, I; Iida, S; Akano, Y; Hayami, Y; Kato, M; Miura, K; Harada, S; Banno, S; Wakita, A; Kiyoi, H; Naoe, T; Shimizu, S; Sonta, S; Nitta, M; Taniwaki, M; Ueda, R
      Ectopic expression of MAFB gene in human myeloma cells carrying (14;20)(q32;q11) chromosomal translocations

      JAPANESE JOURNAL OF CANCER RESEARCH
    3. Kosugi, H; Ito, M; Yamamoto, Y; Towatari, M; Ito, M; Ueda, R; Saito, H; Naoe, T
      In vivo effects of a histone deacetylase inhibitor, FK228, on human acute promyelocytic leukemia in NOD/Shi-scid/scid mice

      JAPANESE JOURNAL OF CANCER RESEARCH
    4. Kunishima, S; Naoe, T; Kamiya, T; Saito, H
      Novel heterozygous missense mutation in the platelet glycoprotein Ib beta gene associated with isolated giant platelet disorder

      AMERICAN JOURNAL OF HEMATOLOGY
    5. Naoe, T; Kiyoi, H; Yamamoto, Y; Minami, Y; Yamamoto, K; Ueda, R; Saito, H
      FLT3 tyrosine kinase as a target molecule for selective antileukemia therapy

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    6. Hirose, Y; Kiyoi, H; Itoh, K; Kato, K; Saito, H; Naoe, T
      B-cell precursors differentiated from cord blood CD34(+) cells are more immature than those derived from granulocyte colony-stimulating factor-mobilized peripheral blood CD34(+) cells

      IMMUNOLOGY
    7. Yamamoto, Y; Kiyoi, H; Nakano, Y; Suzuki, R; Kodera, Y; Miyawaki, S; Asou, N; Kuriyama, K; Yagasaki, F; Shimazaki, C; Akiyama, H; Saito, K; Nishimura, M; Motoji, T; Shinagawa, K; Takeshita, A; Saito, H; Ueda, R; Ohno, R; Naoe, T
      Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies

      BLOOD
    8. Naoe, T; Takeyama, K; Yokozawa, T; Kiyoi, H; Seto, M; Uike, N; Ino, T; Utsunomiya, A; Maruta, A; Jin-Nai, I; Kamada, N; Kubota, Y; Nakamura, H; Shimazaki, C; Horiike, S; Kodera, Y; Saito, H; Ueda, R; Wiemels, J; Ohno, R
      Analysis of genetic polymorphism in NQO1, GST-M1, GST-T1, and CYP3A4 in 469 Japanese patients with therapy-related Leukemia/Myelodysplastic Syndrome and de novo acute myeloid leukemia

      CLINICAL CANCER RESEARCH
    9. Naoe, T; Nakano, Y; Kiyoi, H
      Leukemia relapse reconsidered from the molecular aspect

      LEUKEMIA & LYMPHOMA
    10. Hayakawa, F; Towatari, M; Kiyoi, H; Tanimoto, M; Kitamura, T; Saito, H; Naoe, T
      Tandem-duplicated Flt3 constitutively activates STAT5 and MAP kinase and introduces autonomous cell growth in IL-3-dependent cell lines

      ONCOGENE
    11. Murata, M; Towatari, M; Kosugi, H; Tanimoto, M; Ueda, R; Saito, H; Naoe, T
      Apoptotic cytotoxic effects of a histone deacetylase inhibitor, FK228, on malignant lymphoid cells

      JAPANESE JOURNAL OF CANCER RESEARCH
    12. Nakano, Y; Naoe, T; Kiyoi, H; Kitamura, K; Minami, S; Miyawaki, S; Asou, N; Kuriyama, K; Kusumoto, S; Shimazaki, C; Akiyama, H; Saito, K; Nishimura, M; Motoji, T; Shinagawa, K; Saito, H; Ohno, R
      Prognostic value of p53 gene mutations and the product expression in de novo acute myeloid leukemia

      EUROPEAN JOURNAL OF HAEMATOLOGY
    13. Zhao, M; Kiyoi, H; Yamamoto, Y; Ito, M; Towatari, M; Omura, S; Kitamura, T; Ueda, R; Saito, H; Naoe, T
      In vivo treatment of mutant FLT3-transformed murine leukemia with a tyrosine kinase inhibitor

      LEUKEMIA
    14. Kitamura, K; Minami, Y; Yamamoto, K; Akao, Y; Kiyoi, H; Saito, H; Naoe, T
      Involvement of CD95-independent caspase 8 activation in arsenic trioxide-induced apoptosis

      LEUKEMIA
    15. Yokozawa, T; Towatari, M; Iida, H; Takeyama, K; Tanimoto, M; Kiyoi, H; Motoji, T; Asou, N; Saito, K; Takeuchi, M; Kobayashi, Y; Miyawaki, S; Kodera, Y; Ohno, R; Saito, H; Naoe, T
      Prognostic significance of the cell cycle inhibitor p27(Kip1) in acute myeloid leukemia

      LEUKEMIA
    16. Mason, R; Nakase, N; Naoe, T
      Craft education in lower secondary schools in England and Japan: a comparative study

      COMPARATIVE EDUCATION
    17. Kitagawa, N; Goto, M; Kurozumi, K; Maruo, S; Fukayama, M; Naoe, T; Yasukawa, M; Hino, K; Suzuki, T; Todo, S; Takada, K
      Epstein-Barr virus-encoded poly(A)- RNA supports Burkitt's lymphoma growththrough interleukin-10 induction

      EMBO JOURNAL
    18. Nakano, Y; Naoe, T; Kiyoi, H; Kunishima, S; Minami, S; Miyawaki, S; Asou, N; Kuriyama, K; Saito, H; Ohno, R
      Poor clinical significance of p53 gene polymorphism in acute myeloid leukemia

      LEUKEMIA RESEARCH
    19. Kitamura, K; Hoshi, S; Koike, M; Kiyoi, H; Saito, H; Naoe, T
      Histone deacetylase inhibitor but not arsenic trioxide differentiates acute promyelocytic leukaemia cells with t(11;17) in combination with all-transretinoic acid

      BRITISH JOURNAL OF HAEMATOLOGY
    20. Takeshita, A; Shinjo, K; Naito, K; Ohnishi, K; Sugimoto, Y; Yamakawa, Y; Tanimoto, M; Kitamura, K; Naoe, T; Ouno, R
      Role of P-glycoprotein in all-trans retinoic acid (ATRA) resistance in acute promyelocytic leukaemia cells: analysis of intracellular concentration of ATRA

      BRITISH JOURNAL OF HAEMATOLOGY
    21. Yoshida, M; Tsubaki, K; Kobayashi, T; Tanimoto, M; Kuriyama, K; Murakami, H; Minami, S; Hiraoka, A; Takahashi, I; Naoe, T; Asou, N; Kageyama, S; Tomonaga, M; Saito, H; Ohno, R
      Infectious complications during remission induction therapy in 577 patients with acute myeloid leukemia in the Japan Adult Leukemia Study Group studies between 1987 and 1991

      INTERNATIONAL JOURNAL OF HEMATOLOGY
    22. Miyawaki, S; Kobayashi, T; Tanimoto, M; Kuriyama, K; Murakami, H; Yoshida, M; Minami, S; Minato, K; Tsubaki, K; Omoto, E; Oh, H; Jinnai, I; Sakamaki, H; Hiraoka, A; Kanamura, A; Takahashi, I; Saito, K; Naoe, T; Yamada, O; Asou, N; Kageyama, S; Emi, N; Ueda, T; Tomonaga, M; Saito, H; Ueda, R; Ohno, R
      Comparison of leukopenia between cytarabine and behenoyl cytarabine in JALSG AML-89 consolidation therapy

      INTERNATIONAL JOURNAL OF HEMATOLOGY
    23. Kosugi, H; Towatari, M; Hatano, S; Kitamura, K; Kiyoi, H; Kinoshita, T; Tanimoto, M; Murate, T; Kawashima, K; Saito, H; Naoe, T
      Histone deacetylase inhibitors are the potent inducer/enhancer of differentiation in acute myeloid leukemia: a new approach to anti-leukemia therapy

      LEUKEMIA
    24. Kiyoi, H; Naoe, T
      Reply - Review of the immunoglobulin light chain variable region sequencesfrom multiple myeloma cells

      LEUKEMIA
    25. Yanagi, M; Shinjo, K; Takeshita, A; Tobita, T; Yano, K; Kobayashi, M; Terasaki, H; Naoe, T; Ohnishi, K; Ohno, R
      Simple and reliably sensitive diagnosis and monitoring of Philadelphia chromosome-positive cells in chronic myeloid leukemia by interphase fluorescence in situ hybridization of peripheral blood cells

      LEUKEMIA
    26. Iida, M; Towatari, M; Nakao, A; Iida, H; Kiyoi, H; Nakano, Y; Tanimoto, M; Saito, H; Naoe, T
      Lack of constitutive activation of MAP kinase pathway in human acute myeloid leukemia cells with N-Ras mutation

      LEUKEMIA
    27. Mizuta, S; Ito, Y; Kohno, A; Kiyoi, H; Miyamura, K; Tanimoto, M; Takamatsu, J; Naoe, T; Morishima, Y; Ueda, R; Saito, H
      Accurate quantitation of residual tumor burden at bone marrow harvest predicts timing of subsequent relapse in patients with common ALL treated by autologous bone marrow transplantation

      BONE MARROW TRANSPLANTATION
    28. Nakano, Y; Kiyoi, H; Miyawaki, S; Asou, N; Ohno, R; Saito, H; Naoe, T
      Molecular evolution of acute myeloid leukaemia in relapse: unstable N-ras and FLT3 genes compared with p53 gene

      BRITISH JOURNAL OF HAEMATOLOGY
    29. Naoe, T; Kitamura, K
      Relationship between degradation of PML-RAR alpha and differentiation

      BLOOD
    30. Kiyoi, H; Naoe, T; Nakano, Y; Yokota, S; Minami, S; Miyawaki, S; Asou, N; Kuriyama, K; Jinnai, I; Shimazaki, C; Akiyama, H; Saito, K; Oh, H; Motoji, T; Omoto, E; Saito, H; Ohno, R; Ueda, R
      Prognostic implication of FLT3 and N-RAS gene mutations in acute myeloid leukemia

      BLOOD
    31. TAKAHASHI Y; HORIBE K; KIYOI H; MIYASHITA Y; FUKUDA M; MORI H; NOZAKI C; HASEGAWA S; KAWABE T; KATO K; KOJIMA S; MATUYAMA T; NAOE T
      PROGNOSTIC-SIGNIFICANCE OF TEL AML1 FUSION TRANSCRIPT IN CHILDHOOD B-PRECURSOR ACUTE LYMPHOBLASTIC-LEUKEMIA/

      Journal of pediatric hematology/oncology
    32. UEDA T; MIYAWAKI S; ASOU N; KURAISHI Y; HIRAOKA A; KURIYAMA K; MINAMI S; OHSHIMA T; INO T; TAMURA J; KANAMARU A; NISHIKAWA K; TANIMOTO M; OH H; SAITO K; NAGATA K; NAOE T; YAMADA O; URASAKI Y; SAKURA T; OHNO R
      RESPONSE-ORIENTED INDIVIDUALIZED INDUCTION THERAPY WITH 6 DRUGS FOLLOWED BY 4 COURSES OF INTENSIVE CONSOLIDATION, 1 YEAR MAINTENANCE AND INTENSIFICATION THERAPY - THE ALL90 STUDY OF THE JAPAN ADULT LEUKEMIA STUDY-GROUP

      International journal of hematology
    33. Tanimoto, M; Miyawaki, S; Ino, T; Kyo, T; Sakamaki, H; Naoe, T; Hiraoka, A; Asou, N; Ohshima, T; Tsubaki, K; Kuriyama, K; Ueda, T; Minamil, S; Okabe, K; Saito, H; Murakami, H; Hirano, M; Dohy, H; Onozawa, Y; Suzuki, H; Ohno, R
      Response-oriented individualized induction therapy followed by intensive consolidation and maintenance for adult patients with acute lymphoblastic leukemia: The ALL-87 Study of the Japan Adult Leukemia Study Group (JALSG)

      INTERNATIONAL JOURNAL OF HEMATOLOGY
    34. IWANAGA M; KUNISHIMA S; IKEDA S; TOMONAGA M; NAOE T
      VULNERABLE MUTATION TRP126-]STOP OF GLYCOPROTEIN-IX IN JAPANESE BERNARD-SOULIER-SYNDROME

      European journal of haematology
    35. KIYOI H; TOWATARI M; YOKOTA S; HAMAGUCHI M; OHNO R; SAITO H; NAOE T
      INTERNAL TANDEM DUPLICATION OF THE FLT3 GENE IS A NOVEL MODALITY OF ELONGATION MUTATION WHICH CAUSES CONSTITUTIVE ACTIVATION OF THE PRODUCT

      Leukemia
    36. KUDO K; YOSHIDA H; KIYOI H; NUMATA S; HORIBE K; NAOE T
      ETOPOSIDE-RELATED ACUTE PROMYELOCYTIC LEUKEMIA

      Leukemia
    37. KIYOI H; NAITO K; OHNO R; SAITO H; NAOE T
      CHARACTERIZATION OF THE IMMUNOGLOBULIN LIGHT-CHAIN VARIABLE REGION GENE EXPRESSED IN MULTIPLE-MYELOMA

      Leukemia
    38. YOSHIDA H; KONDO M; ICHIHASHI T; HASHIMOTO N; INAZAWA J; OHNO R; NAOE T
      A NOVEL MYELOID CELL-LINE, MARIMO, DERIVED FROM THERAPY-RELATED ACUTEMYELOID-LEUKEMIA DURING TREATMENT OF ESSENTIAL THROMBOCYTHEMIA - CONSISTENT CHROMOSOMAL-ABNORMALITIES AND TEMPORARY C-MYC GENE AMPLIFICATION

      Cancer genetics and cytogenetics
    39. OHNISHI K; TOMONAGA M; KAMADA N; ONOZAWA K; KURAMOTO A; DOHY H; MIZOGUCHI H; MIYAWAKI S; TSUBAKI K; MIURA Y; OMINE M; KOBAYASHI T; NAOE T; OHSHIMA T; HIRASHIMA K; OHTAKE S; TAKAHASHI I; MORISHIMA Y; NAITO K; ASOU N; TANIMOTO M; SAKUMA A; OHNO R
      A LONG-TERM FOLLOW-UP OF A RANDOMIZED TRIAL COMPARING INTERFERON-ALPHA WITH BUSULFAN FOR CHRONIC MYELOGENOUS LEUKEMIA

      Leukemia research
    40. AKAO Y; MIZOGUCHI H; KOJIMA S; NAOE T; OHISHI N; YAGI K
      ARSENIC INDUCES APOPTOSIS IN B-CELL LEUKEMIC-CELL LINES IN-VITRO - ACTIVATION OF CASPASES AND DOWN-REGULATION OF BCL-2 PROTEIN

      British Journal of Haematology
    41. HAYAKAWA F; TOWATARI M; IIDA H; WAKAO H; KIYOI H; NAOE T; SAITO H
      DIFFERENTIAL CONSTITUTIVE ACTIVATION BETWEEN STAT-RELATED PROTEINS AND MAP KINASE IN PRIMARY ACUTE MYELOGENOUS LEUKEMIA

      British Journal of Haematology
    42. KUNISHIMA S; MIZUNO S; NAOE T; SAITO H; KAMIYA T
      GENES FOR THROMBOPOIETIN AND C-MPL ARE NOT RESPONSIBLE FOR FAMILIAL THROMBOCYTHEMIA - A CASE-STUDY

      British Journal of Haematology
    43. MAKISHIMA M; UMESONO K; SHUDO K; NAOE T; KISHI K; HONMA Y
      INDUCTION OF DIFFERENTIATION IN ACUTE PROMYELOCYTIC LEUKEMIA-CELLS BY9-CIS RETINOIC ACID ALPHA-TOCOPHEROL ESTER (9-CIS TRETINOIN TOCOFERIL)

      Blood
    44. KUNISHIMA S; HEATON DC; NAOE T; HICKTON C; MIZUNO S; SAITO H; KAMIYA T
      DE-NOVO MUTATION OF THE PLATELET GLYCOPROTEIN IB-ALPHA GENE IN A PATIENT WITH PSEUDO-VON-WILLEBRAND-DISEASE

      Blood coagulation & fibrinolysis
    45. YUASA H; HAMAJIMA N; UEDA R; OHNO R; ASOU N; UTSUNOMIYA A; OGURA M; TAKIGAWA N; UEDA T; HIRAOKA A; MATSUDA S; KURAISHI Y; NISHIKAWA K; UIKE N; TAKESHITA A; TAKEMOTO Y; SHIMAZAKI C; SAKAMAKI H; INO T; MATSUSHIMA T; KURIYAMA K; HIRAI H; NAOE T; TSUBAKI K; TAKAHASHI M; TAKEYAMA K; MORISHIMA Y; ITOH K; OMOTO E; HODOHARA K; TAKAHASHI I
      CASE-CONTROL STUDY OF LEUKEMIA AND DIAGNOSTIC RADIATION EXPOSURE

      International journal of hematology
    46. KITAMURA K; YOSHIDA H; OHNO R; NAOE T
      TOXIC EFFECTS OF ARSENIC (AS3-IONS ON ACUTE PROMYELOCYTIC LEUKEMIA-CELLS() AND OTHER METAL)

      International journal of hematology
    47. KIYOI H; NAOE T; YOKOTA S; NAKAO M; MINAMI S; KURIYAMA K; TAKESHITA A; SAITO K; HASEGAWA S; SHIMODAIRA S; TAMURA J; SHIMAZAKI C; MATSUE K; KOBAYASHI H; ARIMA N; SUZUKI R; MORISHITA H; SAITO H; UEDA R; OHNO R
      INTERNAL TANDEM DUPLICATION OF FLT3 ASSOCIATED WITH LEUKOCYTOSIS IN ACUTE PROMYELOCYTIC LEUKEMIA

      Leukemia
    48. MORI H; KIYOI H; HORIBE K; OHNO R; NAOE T
      COMPARISON OF THE IMMUNOGLOBULIN GENE TRANSCRIPTS BETWEEN IMMATURE B-LINEAGE ACUTE LYMPHOBLASTIC-LEUKEMIA AND THE NORMAL PHENOTYPIC COUNTERPARTS IN THE BONE-MARROW

      Leukemia
    49. KITAMURA K; KIYOI H; YOSHIDA H; SAITO H; OHNO R; NAOE T
      MUTANT AF-2 DOMAIN OF PML-RAR-ALPHA IN RETINOIC ACID-RESISTANT NB4 CELLS - DIFFERENTIATION-INDUCED BY RA IS TRIGGERED DIRECTLY THROUGH PML-RAR-ALPHA AND ITS DOWN-REGULATION IN ACUTE PROMYELOCYTIC LEUKEMIA

      Leukemia
    50. YOKOTA S; KIYOI H; NAKAO M; IWAI T; MISAWA S; OKUDA T; SONODA Y; ABE T; KAHSIMA K; MATSUO Y; NAOE T
      INTERNAL TANDEM DUPLICATION OF THE FLT3 GENE IS PREFERENTIALLY SEEN IN ACUTE MYELOID-LEUKEMIA AND MYELODYSPLASTIC SYNDROME AMONG VARIOUS HEMATOLOGICAL MALIGNANCIES - A STUDY ON A LARGE SERIES OF PATIENTS AND CELL-LINES

      Leukemia
    51. KITAMURA K; KIYOI H; YOSHIDA H; TOBITA T; TAKESHITA A; OHNO R; NAOE T
      NEW RETINOIDS AND ARSENIC COMPOUNDS FOR THE TREATMENT OF REFRACTORY ACUTE PROMYELOCYTIC LEUKEMIA - CLINICAL AND BASIC STUDIES FOR THE NEXT-GENERATION

      Cancer chemotherapy and pharmacology
    52. YAMANAKA K; KUBO K; KIYOI H; ICHIHASHI T; KATO K; HORIBE K; NAOE T
      UNUSUAL FEATURE OF THE T-CELL RECEPTOR GENES IN T-LINEAGE ACUTE LYMPHOBLASTIC-LEUKEMIA

      Leukemia research
    53. NOZAKI N; NAOE T; OKAZAKI T
      IMMUNOAFFINITY PURIFICATION AND CHARACTERIZATION OF CACGTG SEQUENCE-BINDING PROTEINS FROM CULTURED-MAMMALIAN-CELLS USING AN ANTI C-MYC MONOCLONAL-ANTIBODY RECOGNIZING THE DNA-BINDING DOMAIN

      Journal of Biochemistry
    54. MATSUI T; KUNISHIMA S; HAMAKO J; KATAYAMA M; KAMIYA T; NAOE T; OZEKI Y; FUJIMURA Y; TITANI K
      INTERACTION OF VON-WILLEBRAND-FACTOR WITH THE EXTRACELLULAR-MATRIX AND GLYCOCALICIN UNDER STATIC CONDITIONS

      Journal of Biochemistry
    55. TOBITA T; TAKESHITA A; KITAMURA K; OHNISHI K; YANAGI M; HIRAOKA A; KARASUNO T; TAKEUCHI M; MIYAWAKI S; UEDA R; NAOE T; OHNO R
      TREATMENT WITH A NEW SYNTHETIC RETINOID, AM80, OF ACUTE PROMYELOCYTICLEUKEMIA RELAPSED FROM COMPLETE REMISSION INDUCED BY ALL-TRANS-RETINOIC ACID

      Blood
    56. KUDO K; YOSHIDA H; KIYOI H; HORIBE K; NAOE T; MURATE T
      CLUSTERED BREAKPOINTS OF T(15-17) IN ETOPOSIDE-RELATED ACUTE PROMYELOCYTIC LEUKEMIA PRECEDED BY LANGERHANS CELL HISTIOCYTOSIS

      Blood
    57. CHEN GQ; SHI XG; TANG W; XIONG SM; ZHU J; CAI X; HAN ZG; NI JH; SHI GY; JIA PM; LIU MM; HE KL; NIU C; MA J; ZHANG P; ZHANG TD; PAUL P; NAOE T; KITAMURA K; MILLER W; WAXMAN S; WANG ZY; DETHE H; CHEN SJ; CHEN Z
      USE OF ARSENIC TRIOXIDE (AS2O3) IN THE TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA (APL) .1. AS2O3 EXERTS DOSE-DEPENDENT DUAL EFFECTS ON APL CELLS

      Blood
    58. KUNISHIMA S; LOPEZ JA; KOBAYASHI S; IMAI N; KAMIYA T; SAITO H; NAOE T
      MISSENSE MUTATIONS OF THE GLYCOPROTEIN (GP) IB-BETA GENE IMPAIRING THE GPIB ALPHA BETA DISULFIDE LINKAGE IN A FAMILY WITH GIANT PLATELET DISORDER/

      Blood
    59. KAGAMI Y; ARIYOSHI Y; HORIUCHI A; KANAMARU A; KANO Y; NAOE T; OGURO M; OHNO R; SAMPI K; SHIRAKAWA S; MASAOKA T; FURUE H
      FEASIBILITY OF SALVAGE CHEMOTHERAPY FOR REFRACTORY OR RELAPSED NON-HODGKINS-LYMPHOMA WITH 2 TOPOISOMERASE-II INHIBITORS, MST-16 AND VP-16

      International journal of hematology
    60. KUNISHIMA S; TAHARA T; KATO T; KOBAYASHI S; SAITO H; NAOE T
      SERUM THROMBOPOIETIN AND PLASMA GLYCOCALICIN CONCENTRATIONS AS USEFULDIAGNOSTIC MARKERS IN THROMBOCYTOPENIC DISORDERS

      European journal of haematology
    61. KUNISHIMA S; KOBAYASHI S; NAOE T
      INCREASED BUT HIGHLY DISPERSED LEVELS OF PLASMA GLYCOCALICIN IN PATIENTS WITH DISSEMINATED INTRAVASCULAR COAGULATION

      European journal of haematology
    62. KIYOI H; NAITO K; OHNO R; NAOE T
      COMPARABLE GENE STRUCTURE OF THE IMMUNOGLOBULIN HEAVY-CHAIN VARIABLE REGION BETWEEN MULTIPLE-MYELOMA AND NORMAL BONE-MARROW LYMPHOCYTES

      Leukemia
    63. KOBAYASHI T; MIYAWAKI S; TANIMOTO M; KURIYAMA K; MURAKAMI H; YOSHIDA M; MINAMI S; MINATO K; TSUBAKI K; OHMOTO E; OH H; JINNAI I; SAKAMAKI H; HIRAOKA A; KANAMARU A; TAKAHASHI I; SAITO K; NAOE T; YAMADA O; ASOU N; KAGEYAMA S; EMI N; MATSUOKA A; TOMONAGA M; SAITO H; UEDA R; OHNO R
      RANDOMIZED TRIALS BETWEEN BEHENOYL CYTARABINE AND CYTARABINE IN COMBINATION INDUCTION AND CONSOLIDATION THERAPY, AND WITH OR WITHOUT UBENIMEX AFTER MAINTENANCE INTENSIFICATION THERAPY IN ADULT ACUTE MYELOID-LEUKEMIA

      Journal of clinical oncology
    64. TAMURA K; MIYAZAKI T; SAKURADA K; KASAI M; KAWAMURA K; YOSHIDA Y; SAKATA Y; TAKAMI H; UZUKA Y; SAITOU Y; HATTORI M; SANPI K; TAKAGI T; SAKAI T; OGAWA M; MIZUNUMA N; KURAISHI Y; KOBAYASHI S; TOYAMA K; KIMURA Y; MIZOGUCHI H; HOSHINO S; OHSHIMA T; TAKEUCHI H; FUJITA H; SAITO H; OHNO R; YAMADA K; NAOE T; KIMURA K; INAGAKI J; HIRANO M; EZAKI K; OKAMOTO M; SHIRAKAWA S; KOBAYASHI T; MASAOKA T; SHIBATA H; NAKAMURA T; FUKUSHIMA T; KUMURA I; TAKAHASHI I; TOKI H; OKABE K; KURAMOTO A; MAEHAMA S; ICHIMARU M; MORIUCHI Y; MASUMOTO M; MATSUMOTO T
      A PHASE-I STUDY OF IDARUBICIN HYDROCHLORIDE IN PATIENTS WITH ACUTE-LEUKEMIA

      Seminars in hematology
    65. KIYOI H; MORI H; HORIBE K; OHNO R; NAOE T
      COMPARISON OF THE IMMUNOGLOBULIN HEAVY-CHAIN COMPLEMENTARITY-DETERMINING REGION-3 STRUCTURE AMONG THE DNA-SEQUENCES AND THE MU-TRANSCRIPT AND GAMMA-TRANSCRIPT IN HUMAN B-LINEAGE CELLS

      Immunology
    66. YOSHIDA H; KITAMURA K; TANAKA K; OMURA S; MIYAZAKI T; HACHIYA T; OHNO R; NAOE T
      ACCELERATED DEGRADATION OF PML-RETINOIC ACID RECEPTOR-ALPHA (PML-RARA) ONCOPROTEIN BY ALL-TRANS-RETINOIC ACID IN ACUTE PROMYELOCYTIC LEUKEMIA - POSSIBLE ROLE OF THE PROTEASOME PATHWAY

      Cancer research
    67. MARUKAWA O; AKAO Y; INAZAWA J; ARIYAMA T; ABE T; NAOE T; TANIMOTO M; SAITO H; OTSUKI Y; TSUJIMOTO Y
      MOLECULAR-CLONING OF THE BREAKPOINT OF T(11-22)(Q23-Q11) CHROMOSOME-TRANSLOCATION IN AN ADULT ACUTE MYELOMONOCYTIC LEUKEMIA

      British Journal of Haematology
    68. CHEN GQ; ZHU J; SHI XG; NI JH; ZHONG HJ; SI GY; JIN XL; TANG W; LI XS; XONG SM; SHEN ZX; SUN GL; MA J; ZHANG P; ZHANG TD; GAZIN C; NAOE T; CHEN SJ; WANG ZY; CHEN Z
      IN-VITRO STUDIES ON CELLULAR AND MOLECULAR MECHANISMS OF ARSENIC TRIOXIDE (AS2O3) IN THE TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA - AS2O3 INDUCES NB4 CELL APOPTOSIS WITH DOWN-REGULATION OF BCL-2 EXPRESSION AND MODULATION OF PML-RAR-ALPHA PML PROTEINS/

      Blood
    69. KUBO K; YAMANAKA K; KIYOI H; FUKUTANI H; ITO M; HAYAKAWA R; OHNO R; NAOE T
      DIFFERENT T-CELL RECEPTOR REPERTOIRES BETWEEN LESIONS AND PERIPHERAL-BLOOD IN ACUTE GRAFT-VERSUS-HOST DISEASE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION

      Blood
    70. ICHIHASHI T; NAOE T; OHNO R
      ATLAS OF BLOOD-DISEASE ON THE INTERNET

      Blood
    71. YOSHIDA H; NAOE T; FUKUTANI H; KIYOI H; KUBO K; OHNO R
      ANALYSIS OF THE JOINING SEQUENCES OF THE T(15-17) TRANSLOCATION IN HUMAN ACUTE PROMYELOCYTIC LEUKEMIA - SEQUENCE NONSPECIFIC RECOMBINATION BETWEEN THE PML AND RARA GENES WITHIN IDENTICAL SHORT STRETCHES

      Genes, chromosomes & cancer
    72. FUKUTANI H; NAOE T; OHNO R; YOSHIDA H; MIYAWAKI S; SHIMAZAKI C; MIYAKE T; NAKAYAMA Y; KOBAYASHI H; GOTO S; TAKESHITA A; KOBAYASHI S; KATO Y; SHIRAISHI K; SASADA M; OHTAKE S; MURAKAMI H; KOBAYASHI M; ENDO N; SHINDO H; MATSUSHITA K; HASEGAWA S; TSUJI K; UEDA Y; TOMINAGA N; FURUYA H; INOUE Y; TAKEUCHI J; MORISHITA H; IIDA H
      ISOFORMS OF PML-RETINOIC ACID RECEPTOR-ALPHA FUSED TRANSCRIPTS AFFECTNEITHER CLINICAL-FEATURES OF ACUTE PROMYELOCYTIC LEUKEMIA NOR PROGNOSIS AFTER TREATMENT WITH ALL-TRANS-RETINOIC ACID

      Leukemia
    73. NAOE T; YOSHIDA H; KITAMURA K; CHINO M; OSUMI K; OHNO R
      DELAYED OR INSUFFICIENT RESTORATION OF PML AND PML-RAR-ALPHA SUBCELLULAR-LOCALIZATION AFTER EXPOSURE IN-VITRO TO RETINOIC ACIDS IN ALL-TRANS-RETINOIC ACID-RESISTANT APL CELLS

      Leukemia
    74. FUKUTANI H; NAOE T; OHNO R; YOSHIDA H; KIYOI H; MIYAWAKI S; MORISHITA H; SANO F; KAMIBAYASHI H; MATSUE K; MIYAKE T; HASEGAWA S; UEDA Y; KATO Y; KOBAYASHI H; SHIMAZAKI C; KOBAYASHI M; KURANE R; SAKOTA H; MASAKI K; WAKAYAMA T; TOHYAMA K; NONAKA Y; NATORI H
      PROGNOSTIC-SIGNIFICANCE OF THE RT-PCR ASSAY OF PML-RARA TRANSCRIPTS IN ACUTE PROMYELOCYTIC LEUKEMIA

      Leukemia
    75. KIYOI H; FUKUTANI H; YAMAUCHI T; KUBO K; OHNO R; YAMAMORI S; NAOE T
      CONTINUING IMMUNOGLOBULIN HEAVY-CHAIN GENE REARRANGEMENTS IN CHRONIC MYELOID-LEUKEMIA WITH RECURRENT B-LYMPHOID BLAST CRISES AFTER BONE-MARROW TRANSPLANTATION

      Leukemia
    76. ZHU J; SHI XG; CHU HY; TONG JH; WANG ZY; NAOE T; WAXMAN S; CHEN SJ; CHEN Z
      EFFECT OF RETINOIC ACID ISOMERS ON PROLIFERATION, DIFFERENTIATION ANDPML RELOCALIZATION IN THE APL CELL-LINE NB4

      Leukemia
    77. KIYOI H; KOJIMA S; KATO K; MATSUYAMA T; KODERA Y; OHNO R; NAOE T
      DETECTION OF MINIMAL RESIDUAL DISEASE IN PATIENTS WITH CHILDHOOD COMMON ACUTE LYMPHOBLASTIC-LEUKEMIA AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION WITH EX-VIVO PURGING AND SYSTEMIC IL-2 INFUSION - UNSUCCESSFUL PREDICTION OF SUBSEQUENT RELAPSE

      Bone marrow transplantation
    78. HIRABAYASHI N; KODERA Y; MATSUYAMA T; TANIMOTO M; HORIBE K; NAOE T; KOJIMA H; YAMADA H; UTSUMI M; MORISHIMA Y; MORISHITA Y; YAZAKI M; YOKOMAKU S; GOTO S; MINAMI S; KOJIMA S; SAITO H
      BONE-MARROW TRANSPLANTATION IN 614 PATIENTS - 20-YEAR EXPERIENCE OF THE NAGOYA-BONE-MARROW-TRANSPLANTATION-GROUP (NBMTG)

      Transplantation proceedings
    79. KIYOI H; NAITO K; OHNO R; NAOE T
      COMPARABLE PROFILES OF THE IMMUNOGLOBULIN HEAVY-CHAIN COMPLEMENTARITY-DETERMINING REGION (CDR)-3 IN CD5(-) HUMAN CORD-BLOOD B-LYMPHOCYTES()AND CD5()

      Immunology
    80. OHNISHI K; OHNO R; TOMONAGA M; KAMADA N; ONOZAWA K; KURAMOTO A; DOHY H; MIZOGUCHI H; MIYAWAKI S; TSUBAKI K; MIURA Y; OMINE M; KOBAYASHI T; NAOE T; OHSHIMA T; HIRASHIMA K; OHTAKE S; TAKAHASHI I; MORISHIMA Y; NAITO K; ASOU N; TANIMOTO M; SAKUMA A; YAMADA K
      A RANDOMIZED TRIAL COMPARING INTERFERON-ALPHA WITH BUSULFAN FOR NEWLY-DIAGNOSED CHROMIC MYELOGENOUS LEUKEMIA IN CHRONIC PHASE

      Blood
    81. NAOE T; KUDO K; YOSHIDA H; HORIBE K; OHNO R
      MOLECULAR ANALYSIS OF THE T(15-17) TRANSLOCATION IN DE-NOVO AND SECONDARY ACUTE PROMYELOCYTIC LEUKEMIA

      Blood
    82. KUNISHIMA S; KOBAYASHI S; IMAI N; LOPEZ JA; SAITO H; NAOE T
      COMPOUND HETEROZYGOSITY FOR MISSENSE MUTATIONS IN THE GLYCOPROTEIN IB-BETA GENE ASSOCIATED WITH HEREDITARY GIANT PLATELET DISORDER

      Blood
    83. KIYOI H; FUKUTANI H; KUBO K; OHNO R; NAOE T
      CHARACTERIZATION OF IMMUNOGLOBULIN HEAVY-CHAIN GENE REARRANGEMENTS INCHRONIC MYELOID-LEUKEMIA WITH RECURRENT B-LYMPHOID BLAST CRISIS FOLLOWING BONE-MARROW TRANSPLANTATION

      Internal medicine
    84. OHNO R; OHNISHI K; TAKESHITA A; TANIMOTO M; MURAKAMI H; KANAMARU A; ASOU N; KOBAYASHI T; KURIYAMA K; OHMOTO E; SAKAMAKI H; TSUBAKI K; HIRAOKA A; YAMADA O; OH H; FURUSAWA S; MATSUDA S; NAOE T
      ALL-TRANS-RETINOIC ACID THERAPY IN RELAPSED REFRACTORY OR NEWLY-DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA (APL) IN JAPAN

      Leukemia
    85. KUNISHIMA S; HATTORI M; KOBAYASHI S; HATTORI H; IWAMA Y; IMAI Y; OGAWA K; NAOE T; OHNO R
      ACTIVATION AND DESTRUCTION OF PLATELETS IN PATIENTS WITH RHEUMATIC HEART-DISEASE

      European heart journal
    86. KOBAYASHI T; MIYAWAKI S; TANIMOTO M; KURIYAMA K; MURAKAMI H; YOSHIDA M; KODERA Y; MINATO K; TSUBAKI K; OHMOTO E; OH H; JINNAI I; SAKAMAKI H; HIRAOKA A; KANAMARU A; TAKAHASHI I; FURUSAWA S; NAOE T; YAMADA O; ASOU N; NISHIKAWA K; OKABE K; OGURA M; TANAKA M; OHNO R
      RANDOMIZED TRIAL BETWEEN BEHENOYL CYTARABINE (BHAC) OR CYTARABINE IN COMBINATION CHEMOTHERAPY OF ADULT ACUTE MYELOID-LEUKEMIA (AML) (JALSG-AML89 PROTOCOL) AND ANALYSIS OF PROGNOSTIC FACTORS

      Blood
    87. KUNISHIMA S; MIURA H; FUKUTANI H; YOSHIDA H; OSUMI K; KOBAYASHI S; OHNO R; NAOE T
      BERNARD-SOULIER-SYNDROME KAGOSHIMA - SER-444-]STOP MUTATION OF GLYCOPROTEIN (GP) IB-ALPHA RESULTING IN CIRCULATING TRUNCATED GPIB-ALPHA ANDSURFACE EXPRESSION OF GPIB-BETA AND GPIX

      Blood
    88. OHNO R; NAOE T; KANAMARU A; YOSHIDA M; HIRAOKA A; KOBAYASHI T; UEDA T; MINAMI S; MORISHIMA Y; SAITO Y; FURUSAWA S; IMAI K; TAKEMOTO Y; MIURA Y; TESHIMA H; HAMAJIMA N
      A DOUBLE-BLIND CONTROLLED-STUDY OF GRANULOCYTE-COLONY-STIMULATING FACTOR STARTED 2 DAYS BEFORE INDUCTION CHEMOTHERAPY IN REFRACTORY ACUTE MYELOID-LEUKEMIA

      Blood
    89. SHIMIZU N; NAOE T; KAWAZOE Y; SAKAGAMI H; NAKASHIMA H; MURAKAMI T; YAMAMOTO N
      LIGNIFIED MATERIALS AS MEDICINAL RESOURCES .6. ANTI-HIV ACTIVITY OF DEHYDROGENATION POLYMER OF P-COUMARIC ACID, A SYNTHETIC LIGNIN, IN A QUASI-INVIVO ASSAY SYSTEM AS AN INTERMEDIARY STEP TO CLINICAL-TRIALS

      Biological & pharmaceutical bulletin
    90. KUBO K; NAOE T; KIYOI H; FUKUTANI H; KATO Y; OGURI T; YAMAMORI S; AKATSUKA Y; KODERA Y; OHNO R
      CLONAL ANALYSIS OF MULTIPLE POINT MUTATIONS IN THE N-RAS GENE IN PATIENTS WITH ACUTE MYELOID-LEUKEMIA

      Japanese journal of cancer research
    91. MATSUOKA A; MIYAMURA K; EMI N; TAHARA T; TANIMOTO M; NAOE T; OHNO R; KAKIZUKA A; EVANS RM; SAITO H
      UNEXPECTED HETEROGENEITY OF PML RAR-ALPHA FUSED MESSENGER-RNA DETECTED BY NESTED POLYMERASE CHAIN-REACTION IN ACUTE PROMYELOCYTIC LEUKEMIA/

      Leukemia
    92. OHNO R; YOSHIDA H; FUKUTANI H; NAOE T; OHSHIMA T; KYO T; ENDOH N; FUJIMOTO T; KOBAYASHI T; HIRAOKA A; MIZOGUCHI H; KODERA Y; SUZUKI H; HIRANO M; AKIYAMA H; AOKI N; SHINDO H; YOKOMAKU S
      MULTIINSTITUTIONAL STUDY OF ALL-TRANS-RETINOIC ACID AS A DIFFERENTIATION THERAPY OF REFRACTORY ACUTE PROMYELOCYTIC LEUKEMIA

      Leukemia
    93. SAKAGAMI H; UTSUMI A; FUJINAGA S; TAKEDA M; NAOE T; KAWAZOE Y
      STIMULATION OF IODINATION AND CYTOKINE PRODUCTION BY DEHYDROGENATION POLYMERS OF PHENYLPROPENOIDS

      Anticancer research
    94. KIYOI H; NAOE T; YAMAUCHI T; FUKATANI H; KUBO K; KOJIMA S; OHNO R
      MINIMAL RESIDUAL DISEASE STATUS IN PRE-B ACUTE LYMPHOBLASTIC-LEUKEMIAPATIENTS AFTER CHEMOTHERAPY AND BONE-MARROW TRANSPLANTATION - ASSESSMENT OF THE ANTILEUKEMIC EFFECTS OF CHEMOTHERAPY AND BMT

      Leukemia research
    95. ASANOMA M; TAKAHASHI K; NAOE T; YAMAMOTO K; MIYABE M; KAWAZOE Y
      SUPPRESSIVE EFFECT OF SOME SYNTHETIC LIGNINS ON CHEMICAL MUTAGENESIS IN SALMONELLA-TYPHIMURIUM AND ON SKIN TUMORIGENESIS PROMOTED BY TPA INMICE

      MUTATION RESEARCH
    96. OHNO R; KOBAYASHI T; TANIMOTO M; HIRAOKA A; IMAI K; ASOU N; TOMONAGA M; TSUBAKI K; TAKAHASHI I; KODERA Y; YOSHIDA M; MURAKAMI H; NAOE T; SHIMOYAMA M; TSUKADA T; TAKEO T; TESHIMA H; ONOZAWA Y; FUJIMOTO K; KURIYAMA K; HORIUCHI A; KIMURA I; MINAMI S; MIURA Y; KAGEYAMA S; TAHARA T; MASAOKA T; SHIRAKAWA S; SAITO H
      RANDOMIZED STUDY OF INDIVIDUALIZED INDUCTION THERAPY WITH OR WITHOUT VINCRISTINE, AND OF MAINTENANCE INTENSIFICATION THERAPY BETWEEN 4 OR 12 COURSES IN ADULT ACUTE MYELOID-LEUKEMIA - AML-87 STUDY OF THE JAPAN ADULT LEUKEMIA STUDY-GROUP

      Cancer
    97. NAOE T; KUBO K; KIYOI H; OHNO R; AKAO Y; YOSHIDA J; KATO K; KOJIMA S; MATSUYAMA T
      INVOLVEMENT OF THE MLL ALL-1 GENE ASSOCIATED WITH MULTIPLE POINT MUTATIONS OF THE N-RAS GENE IN ACUTE MYELOID-LEUKEMIA WITH T(11 17)(Q23 Q25)/

      Blood
    98. KUNISHIMA S; KOBAYASHI S; TAKAGI A; NAOE T; OHNO R
      RAPID DETECTION OF PLASMA GLYCOCALICIN BY A LATEX AGGLUTINATION-TEST - A USEFUL ADJUNCT IN THE DIFFERENTIAL-DIAGNOSIS OF THROMBOCYTOPENIA

      American journal of clinical pathology
    99. ICHIHASHI T; KUBO K; NAOE T; OHNO R
      NUCLEOTIDE-SEQUENCES OF THE VARIABLE REGIONS OF A HUMAN MONOCLONAL-ANTIBODY AGAINST HLA-A1, A23, AND A24

      Tissue antigens
    100. KUBO K; TACHINO J; YAMAGUCHI H; KURACHI T; NAOE T; OHNO R; UEDA K
      A HUMAN MONOCLONAL-ANTIBODY THAT DETECTS HLA-A1-ANTIGENS, A23-ANTIGENS AND A24-ANTIGENS

      Tissue antigens


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 26/01/21 alle ore 07:46:33